FDA Investigator Erin L Mcfiren

Erin L Mcfiren has conducted inspections on 133 sites in 9 countries as of 19 Jun 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
133
Last Inspection Date:
19 Jun 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, United Kingdom of Great Britain and Northern Ireland, Austria, Germany, Ireland, Sweden, France, Switzerland, Italy
FDA Investigators that have inspected at least one site in common with Erin L Mcfiren:
Aimee Cunningham, PhD, Alan C Gion, Althea A Williams, Amanda B Athey, Amy N Chen, Ana Delp Cintron, Ana P Barido, Anastasia M Shields, Angela L Hatzenbuhler, Anthony J Grace, Arie C Menachem, Ashley L Reiber, Ashley M Whitehurst, Atul J Agrawal, Barbara A Crowl, Barbara J Holladay, Barbara Janine Breithaupt, Braedyn K Kromer, Brandon L Mariner, Brentley S Collins, Brian R Yaun, Brooke K Higgins, Bryan J Love, Byungja E Marciante, Candice C Mandera, Cassandra K Johnson, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, Chaltu Nwakijra, Charles E Idjagboro, Charles L Larson, Charles M Kerns, BLT DO, Charles R Bonapace, PhD, Christian D Lynch (CDL), Christina D Mello, Christine M Whitby, CSO, Christopher J Brown, Clarice J Ahn, Concepcion Cruz, Jr, Courtney N Long, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Cynthia L Rakestraw, Daniel J Lahar, Daniel R Azar, Daniel R Tammariello, Daniel T Lee, Danielle S Pearson, David H Smith, David K Glasgow, David L Chon, David P Rice, Jr, Deanne E Knapp, Debra Bower, Denis Mackey, Denise R Beuttenmuller, Dennis L Doupnik, Deyaa Shaheen, Diane Cvan Leeuwen, Diane L Raccasi, Dianne S Alexander, Dolores Harper, Donna Ltartaglino Besone, Douglas A Campbell, Dr. Abhijit Raha, PhD, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dung N Tran, Dylan D Yao, MD, PhD, Edette J Newby, Edward P Potter, Elizabeth D Connell, Elvis D Morton, Emest F Bizjak, Emmanuel A Dimaano, Jr, Eric L Dong, BS, Eric S Pittman, Erin L Sisler, Esaw, Frank J Marciniak, Gabrielle J Swain, Gajendiran Mahadevan, PhD, Gale L Glinecki, Gerald D Bromley, Jr, Gerald N Mcgirl, DDS, Gifford Whitehurst, Jr, Gregson A Joseph, Haoheng Yan, PhD, Heath R Harley, Hector Jcolon Torres, Holly S Simms, Howard Anderson, PhD, Hugh M Mcclure, II, Jacob M Dyer, Jacqueline A O'shaughnessy, PhD, Jacqueline Mdiaz Albertini, James D Planchon, James M Kewley, James M Simpson, James P Stumpff, James W Leonette, Jamie D Swann, Janete F Guardia, Jeanne D Shaffer, Jeffrey A Reed, Jeffrey J Thibodeau, Jeffrey W Shrifter, DPM, Jennifer Swisher, PhD, Jesse P Hardin, Jessica D Nanini, Joanne S Wilson, John A Kadavil, PhD, John Dan, John M Gusto, Johnson, Jonathan B Lewis, Jonathan S Helfgott, Jonathan W Chapman, Joseph A Morkunas, Joseph Binhas, Joseph W Matthews, Joshua D Levin, Jude C Dikes, Julie A Silberberg, Julie D Bringger, Justin A Hefferman, Justin C Fuller, Jyoti B Patel, PhD, Kalavati Suvarna, PhD, Karen A Spencer, Katelyn Astaub Zamperini, Kathleen B Swat, Kenneth Nieves, Kim M Downing, Kimberly Lewandowski Walker, Krista N Flores, Kurt A Brorson, PhD, Lakisha M Williams, Latoya S Oliver Powell, Lauren E Priest, Laurissa S Flowers, LCDR Anastasia M Piliafas Brown, LCDR Cornelius Brown, III, LCDR Wilfred A Darang, Li Lu, PhD, Lindsey L Kirsh, Lori A Carr, Lori Peters, Lori S Lawless, LT Luis O Rodriguez, Lucilla Facchin, Lynette P Salisbury, Marc A Jackson, Jr, Marc S Neubauer, Marcus A Ray, Maria Joselopez Barragan, PhD, Marion W Nadeau, Marlo Ianm Alintanahin, Martin K Yau, PhD, Matthew M Henciak, Melanie W Pishnery, Melissa J Garcia, Merideth K Rose, Michael A Taylor, Michael F Skelly, PhD, Michael J Nerz, Michael P Sheehan, Michael R Fox, Mildred L Mccray, Myra L Gemmill, Myra L Reed, Natasha A Dezinna, Nathaniel R Esaw, Nebil A Oumer, Nichole J Chamberlain, Nicole K Trudel, Nina D Patel, Niraj R Mehta, PhD, Norman K Starks, Normica G Facey, Nutan Mytle, Omotunde O Osunsanmi, Patricia A Morrow, Patricia D Gardner, Patrick C Klotzbuecher, Patrick D Stone, MS, Philip J Snoy, Philip W Beck, Prabhu P Raju, Pratik S Upadhyay, DDC, Qiao Y Bobo, Qin Xu, Rachel C Harrington, Ralph A Erickson, Ralph Jerndal, Richard Heath Coats, Richard Jay Tucker, RS, Richard L Rutherford, Richard W Thornton, Robert D Tollefsen, Robert L Hummel, Robin R Waller, Ronald T Nowalk, Ronald T Weber, Rosanna M Goodrich, Rose Ashley, Roy Baby, Roy R Rinc, Sam H Haidar, PhD, Sandra A Hughes, Sean R Moynihan, MPH, Sena G Dissmeyer, Sherry L Secrist, BLT DO, Shusheen A Alexander, Stacey A Priest, Stephanie A Madison, Stephanie L Shapley, Stephen D Eich, Steven Eastham, Steven J Thurber, Steven Kozlowski, MD, Steven P Donald, Susan M Jackson, Susan M Matthias, Suzanne M Healy, Tamara N Champion, Tammy L Chavis, Tania E Vizcaino, Terrance L Thomas, Theresa M Smedley, Thomas N Adjabeng, Tiki J Dixon, Timothy M Albright, Toyin B Oladimeji, Victor Spanioli, Vincent T Duncan, Viviana Matta, Walter L Fava, Wanda Y Honeyblue, Wayne E Seifert, Wayne L Jefferson, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Xu Michael Di, PhD, Yasamin Ameri, Yehualashet A Gessesse, Zhao Wang, PhD, Zhong Li, PhD, Zhongren Wu

Erin L Mcfiren's Documents

Publish Date Document Type Title
January, 2011 EIR Atul R. Shah M.D., Clinical Investigator - EIR, 2011-01-06
January, 2014 EIR Advarra IRB - EIR, 2014-01-07
May, 2011 FDA 483 U.S. Army Medical Research Institute of Infectious Diseases - Form 483, 2011-05-10
December, 2012 FDA 483 ACell, Inc - Form 483, 2012-12-20
August, 2011 EIR CoreLab Partners - EIR, 2011-08-03
May, 2014 FDA 483 Camtec, Inc. - Form 483, 2014-05-08
May, 2012 FDA 483 Specialty Thearapy Equipment, Inc. - Form 483, 2012-05-25
September, 2010 FDA 483 BioReliance Corporation - Form 483, 2010-09-07
June, 2017 FDA 483 Human Biosciences, Inc. - Form 483, 2017-06-27
April, 2015 FDA 483 Eyegaze Inc. - Form 483, 2015-04-23
November, 2016 FDA 483 DT MedTech, LLC - Form 483, 2016-11-08
June, 2015 FDA 483 IZI Medical Products, LLC - Form 483, 2015-06-04
March, 2014 EIR Roberto Salvatori, M.D. - EIR, 2014-03-07
September, 2012 FDA 483 InVitroCare, Inc - Form 483, 2012-10-04
February, 2012 FDA 483 Medical Supplies Corporation - Form 483, 2012-02-27
January, 2011 FDA 483 Atul R. Shah M.D., Clinical Investigator - Form 483, 2011-01-06
July, 2012 FDA 483 VBM Medizintechnik GmbH - Form 483, 2012-07-05
March, 2013 FDA 483 Calvary Spine, LLC - Form 483, 2013-03-21
July, 2014 FDA 483 New Horizons Diagnostics Corporation - Form 483, 2014-07-21
July, 2013 EIR StageBio - EIR, 2013-07-19
July, 2013 FDA 483 StageBio - Form 483, 2013-07-25
July, 2015 EIR 3CPM Company Inc - EIR, 2015-07-08
May, 2010 FDA 483 Helena Rodbard, MD - Form 483, 2010-05-18
February, 2016 FDA 483 BTE Technologies, LLC - Form 483, 2016-02-26
February, 2017 FDA 483 Talley Group Limited - Form 483, 2017-02-01
February, 2014 FDA 483 Rowny Systems, Inc. - Form 483, 2014-02-10
July, 2015 FDA 483 3CPM Company Inc - Form 483, 2015-07-08
March, 2016 FDA 483 Safeop Surgical Inc. - Form 483, 2016-03-16
September, 2016 FDA 483 NovaSom, Inc. - Form 483, 2016-09-06
September, 2015 FDA 483 US Medical Innovations, LLC - Form 483, 2015-09-15
August, 2011 FDA 483 Shikani Medical, LLC dba The Airway Company - Form 483, 2011-08-25
October, 2010 FDA 483 Human Genome Sciences Inc - Form 483, 2010-09-24
August, 2012 FDA 483 Niel T. Constantine, Ph.D., Clinical Investigator - Form 483, 2012-08-20
July, 2011 FDA 483 Medical Supplies Corporation - Form 483, 2011-07-11

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more